Navigation Links
CoreTherm™ Microwave Thermotherapy System

ProductsCoreTherm™ Microwave Thermotherapy System
Company GYRUS ACMI
Item CoreTherm™ Microwave Thermotherapy System
Features 
  • Intraprostatic temperature monitoring > Temperature monitoring at the point of prostatic tissue ablation
  • Calculated cell-kill > Unique real-time modeling of prostatic cell-kill
  • Intraprostatic blood flow index > Microwave power can be adjusted to account for the variability in each individual patient's intraprostatic blood flow.
Description The CoreTherm Microwave Thermotherapy System is the Next Generation thermotherapy device for the treatment of symptomatic BPH. Other thermotherapy systems treat patients on standard treatment protocols, discounting the effect of each patient's individual intraprostatic blood flow characteristics will have on achieving the desired therapeutic temperatures and therefore, the treatment outcome.The CoreTherm System employs a patented intraprostatic temperature probe that measures actual tissue temperatures at three locations within the prostate. This data is used by the PLFT Software to provide the treating physician the following data:
Real time measurement of temperatures achieved in the prostate.
The dynamic changes in the intraprostatic blood flow during the treatment.
An estimate of tissue destruction by providing real-time Calculated Cell Kill from the actual temperatures achieved and the duration of the treatment.
Info GYRUS ACMI
Customer Service: (508) 804-2600
Web site: http://www.acmicorp.com

Related medicine products :

1. AquaTherm Water-Induced Thermotherapy (WIT) System
2. TherMatrx® Dose Optimized Thermotherapy™
3. Silicone Oil Cannula System - 20 Gauge
4. Silicone Oil Cannula System - 19 Gauge
5. SuperVu Galilean System
6. KOWA nonmyd 7 / VK-2 Digital Imaging System
7. KOWA nonmyd a-D / VK-2 Digital Imaging System
8. Refraction System RT-2100
9. Odyssey Phacoemulsification System
10. SIStem Phacoemulsification System
11. Precisionist Phacoemulsification System
CELL-DYN Sapphire, our flagship solution for high-volume laboratories, utilizes patented MAPSS plus 3-color fluorescent technology for improved lab efficiency....
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
... sulfate ester of DHEA, derived from sulfated ... in adrenal and extradrenal tissues. DHEA is ... adrenal cortex, and is a precursor for ... weak androgenic activity, which for unsulfated DHEA ...
... DSL's unique DHEA-S-7kits feature ... targeted against the C-7 ... molecule, with no cross-reactivity ... Saliva RIA has been ...
Medicine Products:
(Date:3/28/2017)... Georgia (PRWEB) , ... March 28, 2017 , ... ... to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, property ... a leader in the real estate valuation industry for more than 40 years. ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: